MedPath
TGA Approval

NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe (143166)

143166

NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe

Novo Nordisk Pharmaceuticals Pty Ltd

June 5, 2008

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/5d21f6019c3f11ecdc47cc6d5d4141cf.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/d43f4b371c6b2c7a7e943d9fe2762a71.pdf

Active Ingredients

Insulin aspart

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe (143166) - TGA 批准文号 | MedPath